Specific keynote: molecular therapeutics in ovarian cancer

Gynecol Oncol. 2003 Jan;88(1 Pt 2):S88-92; discussion S93-6. doi: 10.1006/gyno.2002.6692.
No abstract available

Publication types

  • Review

MeSH terms

  • Chromosomes, Human, Pair 3
  • Female
  • Genetic Therapy / methods*
  • Humans
  • Lysophospholipids / biosynthesis
  • Lysophospholipids / genetics
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / therapy*
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphoinositide-3 Kinase Inhibitors
  • Receptors, Cell Surface / biosynthesis
  • Receptors, Cell Surface / genetics
  • Receptors, G-Protein-Coupled*
  • Receptors, Lysophosphatidic Acid

Substances

  • Lysophospholipids
  • Phosphoinositide-3 Kinase Inhibitors
  • Receptors, Cell Surface
  • Receptors, G-Protein-Coupled
  • Receptors, Lysophosphatidic Acid